Combined administration of subthreshold doses of the nitric oxide inhibitor, nitro-L-arginine, and muscarinic receptor antagonist, scopolamine, impairs complex maze learning in rats

Behavioural Pharmacology

Volumn 18, Issue 8, 2007, Pages 801-805

  Pistell, Paul J ^a,c   Daffin Jr , Lee W ^a   Nelson, Christopher M ^a   Duffy, Kara B ^a   Bowker, Jonna L ^a   Spangler, Edward L ^a   Ingram, Donald K ^a,c   Devan, Bryan D ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b TOWSON UNIVERSITY   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Age related memory impairment; Cholinergic; Maze learning; Nitric oxide; Rat

Indexed keywords

N(G) NITROARGININE METHYL ESTER; SCOPOLAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; FOOTSHOCK; LEARNING; MALE; MAZE TEST; NONHUMAN; RAT; TASK PERFORMANCE; TREATMENT RESPONSE;

ALZHEIMER DISEASE; ANIMALS; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MAZE LEARNING; MEMORY; MUSCARINIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED F344; SCOPOLAMINE;

EID: 35948957031     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3282f18d2f     Document Type: Article

References (31)

1. Bartus RT (2000). On neurodegenerative diseases, models, and treatment strategies: lesson learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163:495-529.
2. Bartus RT, Dean RL, Beer B, Lippa AS (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-417.
3. Begley JG, Duan W, Chan S, Duff K, Mattson MP (1999). Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J Neurochem 72:1030-1039.
4. Beiko J, Candusso L, Cain DP (1997). The effect of nonspatial water maze pretraining in rats subjected to serotonin depletion and muscarinic receptor antagonism: a detailed behavioural assessment of spatial performance. Behav Brain Res 88:201-211.
5. Bernabeu R, Schmitz P, Faillace MP, Izquierdo I, Medina JH (1996). Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning. NeuroReport 7:585-588.
6. Bernabeu R, Schroder N, Quevedo J, Cammarota M, Izquierdo I, Medina JH (1997). Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation. Neuro Report 8:2221-2224.
7. Bredt DS, Hwang PM, Snyder SH (1990). Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770.
8. Cain DP, Ighanian K, Boon F (2000). Individual and combined manipulation of muscarinic, NMDA, and benzodiazepine receptor activity in the water maze task: implications for a rat model of Alzheimer dementia. Behav Brain Res 111:125-137.
9. Decker MW, McGaugh JL (1989). Effects of concurrent manipulations of cholinergic and noradrenergic function on learning and retention in mice. Brain Res 477:29-37.
10. Decker MW, Gill TM, McGaugh JL (1990). Concurrent muscarinic and beta-adrenergic blockade in rats impairs place-learning in a water maze and retention of inhibitory avoidance. Brain Res 513:81-85.
11. Devan BD, Sierra-Mercado D Jr, Jimenez M, Bowker JL, Duffy KB, Spangler EL, Ingram DK (2004). Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats. Pharmacol Biochem Behav 79:691-699.
12. Devan BD, Duffy KB, Bowker JL, Bharati IS, Nelson CM, Daffin LW Jr, et al. (2005). Phosphodiesterase type 5 (PDE5) inhibition and cognitive enhancement. Drugs Future 30:725-736.
13. Devan BD, Bowker JL, Duffy KB, Bharati IS, Jimenez M, Sierra-Mercado D Jr, et al. (2006). Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition. Psychopharmacology (Berl) 183:439-445.
14. Devan BD, Pistell PJ, Daffin LWJr, Nelson CM, Duffy KB, Bowker JL, et al. (2007). Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor N omega-nitro-L-arginine methyl ester. Eur J Pharmacol 563:134-140.
15. Ikarashi Y, Takahashi A, Ishimaru H, Shiobara T, Maruyama Y (1998). The role of nitric oxide in striatal acetylcholine release induced by N-methyl-D-aspartate. Neurochem Int 33:255-261.
16. Ingram DK, Spangler EL, Iijima S, Ikari H, Kuo H, Greig NH, London ED (1994). Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis. Life Sci 55: 2037-2049.
17. Ingram DK, Shimada A, Spangler EL, Ikari H, Hengemihle J, Kuo H, Greig N (1996). Cognitive enhancement. New strategies for stimulating cholinergic, glutamatergic, and nitric oxide systems. Ann N Y Acad Sci 786:348-361.
18. Krause M, Pedarzani P (2000). A protein phosphatase is involved in the cholinergic suppression of the Ca(2+)-activated K(+) current sI(AHP) in hippocampal pyramidal neurons. Neuropharmacology 39:1274-1283.
19. Kuo H, Hengemihle J, Ingram DK (1997). Nitric oxide synthase in rat brain: age comparisons quantitated with NADPH-diaphorase histochemistry. J Gerontol. Series A, Biol Sci Med Sci 52:B146-B1151.
20. Leonard TO, Lydic R (1995). Nitric oxide synthase inhibition decreases pontine acetylcholine release. NeuroReport 6:1525-1529.
21. Meyer RC, Spangler EL, Kametani H, Ingram DK (1998). Age-associated memory impairment. Assessing the role of nitric oxide. Ann N Y Acad Sci 854:307-317.
22. Noda Y, Yamada K, Nabeshima T (1997). Role of nitric oxide in the effect of aging on spatial memory in rats. Behav Brain Res 83:153-158.
23. Normile HJ, Altman HJ (1992). Effects of combined acetylcholinesterase inhibition and serotonergic receptor blockade on age-associated memory impairments in rats. Neurobiol Aging 13:735-740.
24. Prickaerts J, Steinbusch HW, Smits JF, de Vente J (1997). Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast. Eur J Pharmacol 337:125-136.
25. Reddy DS, Kulkarni SK (1998). Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res 799:215-229.
26. Saber AJ, Cain DP (2003). Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists. Neuropsychopharmacology 28:1247-1256.
27. Sirvio J (1999). Strategies that support declining cholinergic neurotransmission in Alzheimer's disease patients. Gerontology 45 (Suppl 1):3-14.
28. Spangler EL, Rigby P, Ingram DK (1986). Scopolamine impairs learning performance of rats in a 14-unit T-maze. Pharmacol Biochem Behav 25:673-679.
29. Susswein AJ, Katzoff A, Miller N, Hurwitz I (2004). Nitric oxide and memory. Neuroscientist 10:153-162.
30. Vaucher E, Linville D, Hamel E (1997). Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex. Neuroscience 79:827-836.
31. Whishaw IQ (1989). Dissociating performance and learning deficits on spatial navigation tasks in rats subjected to cholinergic muscarinic blockade. Brain Res Bull 23:347-358.